Rifamycin B
| Catalog No. | KMR055004 |
|---|---|
| CAS No. | 13929-35-6 |
| Alt. name | rifamycin B |
| Formula | C39H49NO14 |
| FW | 755.8 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | [(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienazano)naphtho[2,1-b]furan-9-yl]acetic acid |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Rifamycin B is chemically [(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienazano)naphtho[2,1-b]furan-9-yl]acetic acid .
Rifamycin B is supplied with detailed characterization data compliant with regulatory guideline.
Rifamycin B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Rifamycin B.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMR055008
CAT No: KMR055009
CAT No: KMR055010
CAT No: KMR055001
25-Deacetoxy-25-hydroxyrifamycin S
CAS No.: 17555-51-0
CAT No.: KMR055001
Formula : C35H43NO11
FW : 653.7
CAT No: KMR055002
CAT No: KMR055003
CAT No: KMR055005
CAT No: KMR055006
CAT No: KMR055007
CAT No: KMR055011
